Navigation Links
Researchers unzip MRSA and discover route for vaccine
Date:1/16/2011

University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.

Other MRSA vaccine research has failed to produce a viable option for patients because of the inability to identify an agent that can break through the deadly bacteria's unique armor. Most other research has targeted the surface of the bacteria, but the URMC team discovered an antibody that reaches beyond the microbe's surface and can stop the MRSA bacteria from growing, at least in mice and in cell cultures.

The Orthopaedic Research Society invited URMC researchers to present their findings on Jan. 16, 2011, at the ORS annual meeting in Long Beach, Calif. The team is led by Edward M. Schwarz, Ph.D., professor of Orthopaedics and associate director of the URMC Center for Musculoskeletal Research. John Varrone, a second-year graduate student in Schwarz's lab, will discuss the data at ORS and the ongoing search for attractive molecular candidates for use in a vaccine.

Staph infection is the leading cause of osteomyelitis, a serious bacterial infection of the bone. Up to half of these infections are due to MRSA, a particular strain of staph known as a "superbug" because of its antibiotic resistance. MRSA causes nearly 500,000 hospitalizations and 19,000 deaths a year in the United States. Although improvements in surgical techniques and use of prophylactic antibiotics prevents some MRSA infections, osteomyelitis is expected to remain a serious problem in the future as people live longer and request more joint replacements and reconstructive surgery.

Management of MRSA infections due to bone and joint surgery is very challenging, Schwarz said, and therefore a vaccine to prevent the infection is badly needed.

It is difficult to pin down the source of most post-surgical MRSA infections, but the heal
'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

2

GOOD

Page: 1 2 3

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... As obesity rates sky rocket in the United ... during childbirth comes as no shock. Forceps are surgical equipment ... she is unable to do so herself and although they ... rates of complication for both the mother and the baby. ... and child, forceps births add to the pressure of healthcare ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China ... discuss—for the first time in the U.S.—the need for more ... regulatory process in a timely manner. Representatives from the Taiwan ... best practices and processes in drug review during the ... the DIA 2013 49th Annual Meeting . ...
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 Seven-year-old ... to recovery from autism. He receives 40 hours a ... and school shadowing) from the Center for Autism and ... CARD since August, 2008, and has experienced remarkable progress, ... commenting about his environment. Riley’s personal journey through autism ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network between ... broken, could cut off cancer cell growth at its ... The University of Texas MD Anderson Cancer Center reported ... well-known cancer drug target, and MCM7, a protein vital ... June issue of Cancer Cell . , "MCM7 ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Two months ago, ... going into surgery for a second session of a silicone ... Miami-Dade County. The treatment was allegedly performed by a mystery ... the board. According to Dr. Bernabe Vazquez of ... receiving such treatments from doctor’s who are not board certified ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3
... DIEGO, Nov. 12 Halozyme Therapeutics,Inc. (Nasdaq: HALO ... the extracellular matrix, today announced,that it has been selected ... ), effective Monday, November 19. Launched in 1993, ... in May and November and serves as the basis ...
... Inc., (Nasdaq:,QMED) today announced that it has retained ... alternatives. Lazard Middle Market is the middle,market financial ... with Lazard Middle Market Healthcare Services group will ... of Directors. Additionally, Bruce Wesson, QMed,s Chairman, ...
... Ph.D. program in Nurse Education at Mercer, ... R. Timothy Stack and Mercer University President William,D. ... Healthcare,Chair in Nursing that will benefit Georgia Baptist ... by a $2.85 million grant to the,Center for ...
... training to manage the condition , , MONDAY, Nov. 12 ... illness rather than treating it, but a new study ... difference for people with one tough-to-treat condition: fibromyalgia. , ... moderately for four months reported feeling better in a ...
... The Foundation for the Scientific Study of Sexuality (FSSS) ... Rutgers College of Nursing emerita faculty member Beverly Whipple for ... anniversary meeting of the Society for the Scientific Study of ... Vern L. Bullough Award is given by FSSS for the ...
... November 18 at 9 ... AM ET/PT on Discovery Health -, NEW YORK, ... -- one of the most pressing health crises facing,humanity today. Currently, ... number that is expected to explode to 380,million within 20 years. ...
Cached Medicine News:Health News:Halozyme Therapeutics Added to Nasdaq Biotech Index 2Health News:Piedmont Healthcare Funds Nursing Chair at Mercer University 2Health News:Piedmont Healthcare Funds Nursing Chair at Mercer University 3Health News:Exercise Eases Fibromyalgia Symptoms: Study 2Health News:Exercise Eases Fibromyalgia Symptoms: Study 3Health News:Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 3Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 4
(Date:6/18/2013)... 2013  Recent regulatory and budget challenges have made ... at large pharmaceutical companies to effectively educate doctors and ... of their new products. With the pressure to reduce ... that these "Med Ed" groups find practical, ... address the changes that are transforming the Medical Education ...
(Date:6/18/2013)... Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ... of injectable drug delivery systems, today announced the launch ... The new site includes additional products, videos, features, blogs ... regular basis. Mr. Alan Shortall , ... leader for injectable drug delivery systems, we have created ...
(Date:6/18/2013)... 2013  Specialty Coating Systems is pleased ... coating technologies: SCS microRESIST™ Antimicrobial Parylene Technology. ... with antimicrobial properties to effectively eliminate harmful ... (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ) ... continue to pose a challenge to hospitals ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2Unilife Launches New Corporate Website 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2
... 24, 2011 Omnicell, Inc . (Nasdaq: ... supply chain management solutions to healthcare facilities, today announced ... GS1 standards. GS1 is an international association ... and solutions to improve the efficiency and visibility of ...
... Calif., March 24, 2011 Molecular Devices, Inc. and ... drug discovery tools and solutions, have signed an agreement ... ion channel and GPCR cell lines on a non-exclusive ... will sell ChanTest,s ion channel and GPCR cell lines ...
Cached Medicine Technology:Leading Hospitals Committed to Healthcare's Adoption of GS1 Standards Use Omnicell Solutions for Supply Chain Management 2Leading Hospitals Committed to Healthcare's Adoption of GS1 Standards Use Omnicell Solutions for Supply Chain Management 3Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 2Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 3
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
... Adhesive (Bioglue) is a two-component surgical ... albumin (BSA) and glutaraldehyde. The BSA ... bovine spongiform encephalopathy (BSE) free countries ... inactivates viruses. The solutions are dispensed ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: